Title | Geography | Industry | ||||
---|---|---|---|---|---|---|
Number of ongoing Clinical Trials (for drugs) involving Endometriosis by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Premature Ovarian Failure by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Polycystic Ovarian Syndrome by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Women's Health by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Gynecological Infections by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Miscarriage by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Menstrual Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pregnancy by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Female Contraception by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Anovulation by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Asymmetric (Secondary) Growth Restriction by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Abortion by Phase | Other Industry Indicators | Pakistan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Breast Hyperplasia by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Amenorrhea by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Premenstrual Dysphoric Disorder (PMDD) by Phase | Other Industry Indicators | Sweden | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) by Phase | Other Industry Indicators | Romania | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Protracted Labor by Phase | Other Industry Indicators | Norway | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Post Menopausal Mood Disorder by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Secondary Amenorrhea by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Primary Dysmenorrhea by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Fetal Distress by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Dyspareunia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Menstrual Cramps by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Post Partum Depression (Maternal Depression / Postnatal Depression) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Born Small For Gestational Age (SGA) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Gestational Trophoblastic Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cyclomastopathy by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hormonal Disorders In Post Menopausal Women by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Adnexitis by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Female Genital Prolapse by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Metrorrhagia (Abnormal Uterine Bleeding) by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Intrauterine Growth Restriction by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cervical Intraepithelial Neoplasia (CIN) by Phase | Other Industry Indicators | Zimbabwe | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Fibrocystic Breast Disease by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Vasomotor Symptoms of Menopause (Hot Flashes) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Eclampsia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Unspecified Gynecological Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ovarian Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Lactation Amenorrhea by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Menopausal Disorders by Phase | Other Industry Indicators | Ireland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hormonal Contraception by Phase | Other Industry Indicators | Austria | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Intrauterine Fetal Death by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Disorders of the Breast by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hypothalamic Amenorrhea by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hyperemesis Gravidarum by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ovarian Hyperstimulation Syndrome by Phase | Other Industry Indicators | Brazil | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cervical Ripening In Pregnant Women Near Term by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ectopic Pregnancy (Tubal Pregnancy) by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Premenstrual Syndrome by Phase | Other Industry Indicators | Thailand | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Post Menopausal Disorder by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer